ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ZLAB Zai Lab Ltd

16.16
-0.03 (-0.19%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 780,640
Bid Price 15.86
Ask Price 16.16
News -
Company Name Stock Ticker Symbol Market Type
Zai Lab Ltd ZLAB NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.03 -0.19% 16.16 20:00:00
Open Price Low Price High Price Close Price Prev Close
16.43 15.97 16.46 16.02 16.19
Trades Volume VWAP Dollar Volume Avg Volume
7,295 780,640  16.16  12,611,900 -
Last Trade Time Type Quantity Stock Price Currency
19:40:56 10  16.15 USD

Zai Lab Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 266.72M -334.62M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Zai Lab

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ZLAB Message Board. Create One! See More Posts on ZLAB Message Board See More Message Board Posts

ZLAB Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101.

Your Recent History

Delayed Upgrade Clock